摘要
HIV中和抗体的研究在各方面都取得令人鼓舞的进展 ,为中和抗体机制疫苗的研究注入新的活力。本文综述了中和抗体的作用机制 ,讨论了疫苗构建时如何广泛而有效地诱导中和抗体 。
出处
《国外医学（病毒学分册）》
2004年第1期5-9,共5页
Foreign Medical Sciences(Section of Virology)
参考文献19
-
1Sattentau QJ,Moulard M,Bnvet B,et al.Antibody neutralization of HIV-1 and the potential for vaccine design.Immunol Lett,1999,66(1-3): 143-149.?A
-
2Thomas Lehner.The role of CCR5 chemokine ligands and antibodies to CCR5 corecepotors in poreventing HIV infection.Trends in Immunology,2002,23(7) :347-351.?A
-
3Ruprecht RM,Ferrantelli F,Kitabwalla M,et al.Antibody protection: passive immunization of neonates against oral AIDS virus challenge.Vaccine,2003,21(24):3370-3373.?A
-
4Ferrantelli F,Ruprecht RM.Neutralizing ahtibodies against HIV-back in the major leagues? Current Opinion in Immunology,2002,14:495-502.?A
-
5Saphire EO,Parren PW,Pantophlet R,et al.Crystal structure of a neutralizing human IgG against HIV-1 :A template for vaccine design.Science,2001,293(10): 1155-1159.?A
-
6Ferrantelli F,Rasmussen RA,Hofmann-Lehmann R,et al.Do not underestimate the power of antibodies-lessons from adoptive transfer of antibodies against HIV.Vaccine,2002,20(Suppl 4A)6: 1-6.?A
-
7Chakrabarti BK,Kong W,Wu B,et al.Modifications of the human immunodefiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.J Virol,2002,76(11) :5357-5368.?A
-
8Barnett SW,Lu S,Srivastava I,et al.The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.J Virol,2001,75 (12): 5526-5540.?A
-
9Malenbaum SE,Yang D,Cheng-Mayer C.Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp 120 in humans and macaques.J Virol,2001,75(19) :9287-9296.?A
-
10Devico AL,Fouts TR,Shata MT,et al.Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1 .Vaccine,2002,20(15): 1968-1974.?A
同被引文献43
-
1马红霞,于湘晖,姜春来,吴永革,孔维.中国流行株HIV-1B/C重组亚型包膜蛋白真核表达载体的构建及稳定表达细胞株的筛选[J].中国生物制品学杂志,2006,19(4):365-367. 被引量：2
-
2Nishimura Y, Igarashi T, Haigwood N L, et al. Tranfer of neutralizing IgG to macaques 6 h but not 24h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development[J]. PNAS, 2003, 100 (25): 15131-15136.
-
3Cavacini L A,Duval M,Robinson J, et al. Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions[J], AIDS,2002,16(18):2409-2417.
-
4Holmes H.Osmenov O,Knezevic I, et al. Report of a WHOUNAIDS workshop on progress in the development and standarization of methods to measure HIV-1 neutralizing antibodies in HIV vaccine research and clinical trials[R]. Milan,Italy,7-8 Aug,2003.
-
5Mascola J R,Louder M K, Winter C, et al. Human Immunodeficiency Virus Type 1 Neutralization Measured by Flow Cytometric Quantitation of Single-Round Infection of Primary Human T Cells[J]. J Virol,2002.76:4810-4821.
-
6Spenlehauer C,Gordon C A,Trkola A, et al. A luciferase-reporter gene-expressing T-cell line facilitates neytralization and drug- sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1[J]. Virol,2001,280(2):292-300.
-
7Dong M,Zhang P F, Grieder F, et al. Induction of primary virus-cross -reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system [J]. J Virol, 2003,77:3119-3130.
-
8Shi Y, Albert J, Francis G ,et al. A new cell based neutralization assay for primary HIV type 1 isolates[J]. AIDS Res Hum Retrovirus, 2002,18(13) :957-967.
-
9Kahn P. Cent gardes vaccine meeting highlights roles of antibody in protection[J]. IAVI Report,2002,6(6):1-2.
-
10Saphire E O,Paul W H,Parren I ,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1 : A Template for Vaccine Design[J]. Science, 2001, 293:1155-1159.
引证文献3
-
1许四宏,王佑春.抗HIV-1中和抗体的研究进展[J].中国病毒学,2005,20(3):329-334. 被引量：1
-
2陈斌.治疗艾滋病的构想——多重复合型抗体[J].生物学通报,2007,42(4):60-62.
-
3赵东海,张喜珍,马红霞,孔维,于湘晖.HIV-1中和抗体检测方法的建立[J].中国生物制品学杂志,2008,21(9):810-812. 被引量：1
二级引证文献2
-
1王瑞琴,杨雄,陈红英.HIV VRC01单链抗体的构建、原核表达及纯化[J].西北农林科技大学学报（自然科学版）,2013,41(1):177-182. 被引量：2
-
2郭敏,陈敏,史宣玲,贾曼红,戴洁,傅莉莉,马艳玲,罗红兵,韦焘,李彩霞,徐洪吕,陆林.云南省长期不进展HIV感染者病毒载量和CD4^+T淋巴细胞计数与中和抗体活性相关性分析[J].中国皮肤性病学杂志,2015,29(12):1236-1239.
-
1我国成功研制HIV中和抗体[J].中国高校科技与产业化,2004(6):10-10.
-
2清华大学成功研制HIV中和抗体[J].清华大学学报（自然科学版）,2004,44(8):1086-1086.
-
3我国成功研制HIV中和抗体[J].传染病网络动态,2004(7):17-17.
-
4张冉,易新元,曾宪芳.血吸虫病DNA疫苗的研究进展[J].中国热带医学,2004,4(1):128-130. 被引量：5
-
5美科学家发现HIV中和抗体[J].浙江中西医结合杂志,2010,20(9):590-590.
-
6刘青鹏,王倩.HIV中和抗体抗病毒作用研究进展[J].中国公共卫生,2014,30(8):1090-1093. 被引量：2
-
7姚阳,杨玲,顾康生,杜贤宇,潘跃银,林峰,宋礼华.干扰素结合及中和抗体检测的临床分析[J].中华肝脏病杂志,1998,6(4):251-251. 被引量：1
-
8刘沐桑,郑楠,刘维达.HIV中和抗体在抗HIV感染中的作用[J].国际皮肤性病学杂志,2011,37(1):52-54.
-
9孙爱云,母翠平.运动训练对充血性心力衰竭患者心功能及住院时间的影响[J].菏泽医学专科学校学报,2002,14(3):75-76.
-
10段丽君,江霞.糖尿病下肢动脉病变诊查技术与临床应用进展[J].山西医药杂志（下半月）,2012,41(9):910-912.
